List of specific drug pages

Bendamustine

Bortezomib

Bosutinib

Gefitinib

Nilotinib

Ofatumumab

Paclitaxel

Pazopanib

Salinomycin

Antibiotics

Hormone Suppressant

Taxanes

Retinoids

Mustards

Antibiotics

Inhibitor Drugs

Anthracycline Drugs

Platinums

Naming of Chemo Drugs

Other Drugs

Arsenic Trioxide

Brand/Trade Names: Trisenox

Formula: As2O3

Manufacturers:  ChemCon GmbH, ChemWerth Inc, Emcure Pharmaceuticals, Heraeus Holding

Class:

Administration: Oral

Notes:  First approved by the FDA in 2000.  Used in treatment of leukemia.

Asparaginase

Brand/Trade Names: Elspar, Kidrolase, Rylaze

Formula: C1377H2208N382O442S17

Manufacturers: Jazz Pharmaceuticals, United Biotech Pvt Ltd

Mechanism:

Class: Enzyme

Administration: Intravenous

Notes: Breaks down amino acid asparagine in bloodstream and thereby deprives leukemia cells of supplies of this nutrient.  Also called L-asoaaginase.  Approved by the FDA in 2011.  Used in treatment of acute lymphocytic leukemia. The FDA approved asparaginase erwinia chrysanthemi (recombinant)-rywn in 2021, to help patients who have allergies to E. coli-derived asparaginase.

Eribulin

Brand/Trade Names: Halaven

Manufacturers: Eisai  Inc. Alphora Research  BrightGene Bio-Medical Technology Co.,Ltd  Eisai  Emcure Pharmaceuticals

Formula: C40H59NO11

Mechanism: Mitotic Inhibitor

Class:

Administration: Intravenous

Notes: Approved by the FDA in 2010.  Used for treatment of breast cancer.

Calaspargase pegol-mknl

Brand/Trade Names: Asparlas

Formula:

Manufacturer: Tecoland Corporation

Mechanism: Protein conjugate

Class: Enzyme

Administration: Intravenous

Notes:  Approved by the FDA in 2018.  Used in treatment of acute lymphoblastic leukemia.

Pegaspargase

Brand/Trade Names: Oncaspar

Formula: C1377H2208N382O442S17

Manufacturers: Tecoland Corporation, Baxalta US Inc.

Mechanism:

Class: Enzyme

Administration: Intramuscular or intravenous

Notes: Also called PEG-L-asparaginase.  Approved by the FDA in 1994.  Used in treatment of acute lymphoblastic leukemia.

Pegfilgrastim

Brand/Trade Names: Neulasta, Fulphila

Formula: C845H1343N223O243S9

Manufacturers: Amgen, Mylan Institutional, Coherus BioSciences Inc

Mechanism:

Class: colony-stimulating factor

Administration: Intramuscular or intravenous

Notes:  Approved by the FDA in 2015.  Not an anti-cancer drug. Given to help patient cope with loss of white blood cells.

Tazemetostat

Brand/Trade Names: Tazverik

Formula: C34H44N4O4

Manufacturer: Epizyme

Mechanism: Inhibits histone methyltransferase

Class: Enzyme inhibitor

Administration: Oral

Notes:  Approved by the FDA in 2020. Used for treatment of epithelioid sarcoma.